January 2024 - Page 3 of 3 - BioMedWire (BMW)

FridayJan 05, 2024 1:34 pm

Five Significant Strides Made in Alzheimer’s Research in 2023

Last year was a major year for Alzheimer’s disease research. After spending decades studying the debilitating neurological condition, 2023 saw scientists make significant advancements that opened the door to an entirely new era of Alzheimer’s treatments. The condition affects an estimated 6.7 million Americans and is projected to affect close to 13 million Americans by mid-century. It typically affects people older than 65 years of age and compromises an individual’s thinking, memory, judgment, problem-solving, language and personality as it progresses. Treatments such as cognitive rehabilitation and cognitive stimulation therapy can temporarily improve symptoms, but there currently exists no cure for…

ThursdayJan 04, 2024 10:35 am

New Study Highlights Role of Mitochondria in Connecting Cancer to Dietary Fat

A research study published in the “Seminars in Cancer Biology” journal has revealed that mitochondria may play a key role in the relationship between the development of cancer and dietary fats. The study pointed to new factors that may play a role in the development and progression of medical conditions such as cancer. Interestingly, researchers found that mitochondria, organelles that produce energy for cells, may influence the link between cancer development and dietary fats. On top of sustaining a living organism, diet is also majorly responsible for their quality of life, particularly their susceptibility to various diseases and their ability…

WednesdayJan 03, 2024 10:33 am

Shining Spotlight on How Vitiligo Could Be Connected to Other Autoimmune Disorders

Vitiligo is an autoimmune condition that affects melanin, the pigmentation in the skin, and results in the development of pale-white patches on the skin. It occurs when a person’s immune system becomes dysfunctional and begins to attack melanin cells in the skin, killing the cells off and causing skin regions without pigment cells to become paler. The American Academy of Dermatology notes that there are several types of vitiligo depending on how the patches appear, how much of the skin they cover and their rate of spread. Localized vitiligo typically causes a few patches over small areas of the body,…

TuesdayJan 02, 2024 10:19 am

Study Shows Ongoing Benefits Once Immunotherapy Stops

A study from the University of Texas MD Anderson Cancer Center’s Department of Gastrointestinal Medical Oncology has found that some patients continue to benefit from immunotherapy once the treatment stops. Researchers found that some metastatic colorectal cancer patients are reluctant to stop the treatment as per their doctors’ recommendations, suggesting that discontinuing the treatment doesn’t always stop its benefits. University of Texas MD Anderson Cancer Center associate professor and senior study author Dr. Van Morris and his research team wanted to determine if the health benefits of immunotherapy continued once the treatment was discontinued or due to side effects. The…

TuesdayJan 02, 2024 9:00 am

Clene Inc.’s (NASDAQ: CLNN) Phase 2 REPAIR-PD and REPAIR-MD Trials Indicate CNM-Au8(R)’s Ability to Increase Key Brain Metabolites, Supporting Advancement to Phase 3 Trials

Clene Inc., a late clinical-stage biopharmaceutical company focused on developing solutions that improve mitochondrial health and protect neuronal function to treat neurodegenerative diseases, recently announced the publication of a peer-reviewed article The article describes results from two Phase 2a clinical trials, REPAIR-PD and REPAIR-MS, which evaluated the effects of CNM-Au8, the company’s lead drug candidate, on brain energy metabolite levels in participants with Parkinson’s Disease and Multiple Sclerosis, respectively Researchers measured key brain metabolites, such as NADH and NAD+, which are involved in neuronal energy production, utilization, and maintenance, for changes from baseline with daily, oral treatment of CNM-Au8 over…